Acrivon Therapeutics, Inc. (ACRV) — DEF 14A Filings
All DEF 14A filings from Acrivon Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Acrivon Therapeutics Files 2025 Proxy Statement
— Apr 25, 2025 Risk: low
Acrivon Therapeutics, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting of stockholders. The filing details the company's boar -
Acrivon Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 26, 2024 Risk: low
Acrivon Therapeutics, Inc. (ACRV) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Acrivon Therapeutics, Inc. will hold its 2024 Annual Meeting
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX